JP2025508984A5 - - Google Patents
Info
- Publication number
- JP2025508984A5 JP2025508984A5 JP2024552419A JP2024552419A JP2025508984A5 JP 2025508984 A5 JP2025508984 A5 JP 2025508984A5 JP 2024552419 A JP2024552419 A JP 2024552419A JP 2024552419 A JP2024552419 A JP 2024552419A JP 2025508984 A5 JP2025508984 A5 JP 2025508984A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- homology
- cdr1
- cdr2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2202990.4A GB202202990D0 (en) | 2022-03-03 | 2022-03-03 | Therapeutic antibodies |
| GB2202990.4 | 2022-03-03 | ||
| GB2208544.3 | 2022-06-10 | ||
| GBGB2208544.3A GB202208544D0 (en) | 2022-06-10 | 2022-06-10 | Therapeutic antibodies |
| PCT/GB2023/050512 WO2023166318A2 (en) | 2022-03-03 | 2023-03-03 | Therapeutic antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508984A JP2025508984A (ja) | 2025-04-10 |
| JP2025508984A5 true JP2025508984A5 (enExample) | 2026-02-16 |
Family
ID=85569981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552419A Pending JP2025508984A (ja) | 2022-03-03 | 2023-03-03 | 治療抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250257126A1 (enExample) |
| EP (1) | EP4486775A2 (enExample) |
| JP (1) | JP2025508984A (enExample) |
| KR (1) | KR20240153604A (enExample) |
| AU (1) | AU2023228374A1 (enExample) |
| CA (1) | CA3245384A1 (enExample) |
| WO (1) | WO2023166318A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025097143A1 (en) * | 2023-11-03 | 2025-05-08 | Massachusetts Institute Of Technology | System and method for non-destructive analysis for pre-cancer lesions and harvesting of cells from the same for culture |
| GB202416922D0 (en) | 2024-11-18 | 2025-01-01 | Cambridge Entpr Ltd | Activatable binding molecule |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7446190B2 (en) | 2002-05-28 | 2008-11-04 | Sloan-Kettering Institute For Cancer Research | Nucleic acids encoding chimeric T cell receptors |
| US20100239517A1 (en) | 2007-10-09 | 2010-09-23 | Stephen Brocchini | Novel conjugated proteins and peptides |
| WO2010016766A2 (en) * | 2008-08-08 | 2010-02-11 | Koninklijke Nederlandse Akademie Van Wetenschappen | Antibodies recognizing endogenous human lgr5 and/or lgr6 |
| AR090549A1 (es) * | 2012-03-30 | 2014-11-19 | Genentech Inc | Anticuerpos anti-lgr5 e inmunoconjugados |
| CR20200539A (es) | 2018-04-10 | 2021-07-01 | Kite Pharma Inc | Receptores quiméricos de dll3 y métodos para su uso |
| JP7805928B2 (ja) | 2019-11-26 | 2026-01-26 | ノバルティス アーゲー | Ｃｄ１９及びｃｄ２２キメラ抗原受容体及びその使用 |
-
2023
- 2023-03-03 CA CA3245384A patent/CA3245384A1/en active Pending
- 2023-03-03 EP EP23710421.1A patent/EP4486775A2/en active Pending
- 2023-03-03 KR KR1020247033059A patent/KR20240153604A/ko active Pending
- 2023-03-03 WO PCT/GB2023/050512 patent/WO2023166318A2/en not_active Ceased
- 2023-03-03 AU AU2023228374A patent/AU2023228374A1/en active Pending
- 2023-03-03 JP JP2024552419A patent/JP2025508984A/ja active Pending
- 2023-03-03 US US18/842,730 patent/US20250257126A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI830774B (zh) | 抗cd47抗體及其應用 | |
| TWI796328B (zh) | Ｂ７-ｈ３抗體、其抗原結合片段及其醫藥用途 | |
| JP7295146B2 (ja) | 抗－ｒｏｒ１抗体およびその用途 | |
| CN113321734B (zh) | 抗cd47/抗pd-l1抗体及其应用 | |
| JP7209464B2 (ja) | ヒトインターロイキン－２に対する免疫刺激性モノクローナル抗体 | |
| CN112533955A (zh) | 抗b7-h3抗体 | |
| JP6239503B2 (ja) | 新規な抗ｃｘｃｒ４抗体並びに癌の検出および診断のためのその使用 | |
| WO2019114235A1 (zh) | Pdl1单克隆抗体及其应用 | |
| US12565534B2 (en) | Nano-antibody targeting CAIX antigen and application thereof | |
| KR20110061629A (ko) | 개선된 항체 라이브러리 | |
| JP2005526494A5 (enExample) | ||
| US9676846B2 (en) | Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II | |
| KR20210091254A (ko) | 인간 혈청 알부민에 결합하는 단일 도메인 항체 | |
| CN110770252A (zh) | 抗p53抗体 | |
| TWI815136B (zh) | 一種雙特異性抗體及其用途 | |
| EP3368577A1 (en) | Anti-mesothelin antibodies | |
| TWI906795B (zh) | 特異性結合Ｃｌａｕｄｉｎ １８.２的抗體及其製法和應用 | |
| CN113227148B (zh) | 抗gpc3抗体、其抗原结合片段及其医药用途 | |
| EP4421095A1 (en) | Anti-mesothelin nanobodies and use thereof | |
| CN107849138A (zh) | 抗Aggrus单克隆抗体、与CLEC－2的结合所需的Aggrus的区域和Aggrus－CLEC‐2结合抑制剂的筛选方法 | |
| KR20110122807A (ko) | 피에이유에프(ｐａｕｆ) 특이적인 인간 단일클론항체, 이를 포함하는 암 치료용 조성물, 이를 이용하는 암의 진단방법 | |
| Masuko et al. | Towards therapeutic antibodies to membrane oncoproteins by a robust strategy using rats immunized with transfectants expressing target molecules fused to green fluorescent protein | |
| JP5698254B2 (ja) | ２型糖尿病のためのマーカータンパク質 | |
| CN117242093A (zh) | 免疫组织化学方法和kir3dl2特异性试剂 | |
| CN117545776A (zh) | 基于vhh的nkp30粘结剂 |